Management of antimicrobial-resistant Acinetobacter in hospitals
Tyrone Pitt Deputy director, Laboratory of Healthcare Associated Infection, Centre for Infections, Health Protection Agency, London
This article examines the management of outbreaks of multi-drug resistant (MDR) Acinetobacter in hospitals. It briefly describes the organism and its properties and then discusses its role in disease and the risk to hospital patients, routes of transmission and patient reservoirs, mechanisms of drug resistance and susceptibility to antimicrobial agents, and measures for controlling outbreaks in hospitals. The success of these measures is illustrated by a detailed review of the control of an outbreak of MDR Acinetobacter baumannii infection in an intensive care unit in a London teaching hospital without closure of the ward or isolation of the patients.
Nursing Standard.
21, 35, 51-56.
doi: 10.7748/ns2007.05.21.35.51.c4556
Correspondence
tyrone.pitt@hpa.org.uk
Peer review
This article has been subject to double blind peer review
Want to read more?
Already have access? Log in
or
3-month trial offer for £5.25/month
Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
- Unlimited access to all 10 RCNi Journals
- RCNi Learning featuring over 175 modules to easily earn CPD time
- NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
- Personalised newsletters tailored to your interests
- A customisable dashboard with over 200 topics
Subscribe
Alternatively, you can purchase access to this article for the next seven days.
Buy now
Are you a student? Our student subscription has content especially for you.
Find out more